Capstone Investment Advisors, LLC Seagen Inc. Call Options Transaction History

Capstone Investment Advisors, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 11, 2022	SELL	$142.57 - $190.86 $57,028 - $76,344	-400 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $42,735 - $50,946	-300 Reduced 42.86%	400 $67,000
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $68,755 - $95,400	-500 Reduced 41.67%	700 $97,000
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $197,556 - $254,316	1,200 New	1,200 $210,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Investment Advisors, LLC with notifications on news.